compound 19 [PMID: 33979649]   Click here for help

GtoPdb Ligand ID: 11543

Compound class: Synthetic organic
Comment: This compound was reported as an inhibitor of the papain-like protease (PL-pro) of SARS-CoV-2 [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 9
Topological polar surface area 67.92
Molecular weight 531.3
XLogP 3.82
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN1CCN(CC1)C(=O)Nc1cc(CNC(=O)C2CCN(CC2)[C@@H](c2cccc3c2cccc3)C)cc(c1)F
Isomeric SMILES CN1CCN(CC1)C(=O)Nc1cc(CNC(=O)C2CCN(CC2)[C@@H](c2cccc3c2cccc3)C)cc(c1)F
InChI InChI=1S/C31H38FN5O2/c1-22(28-9-5-7-24-6-3-4-8-29(24)28)36-12-10-25(11-13-36)30(38)33-21-23-18-26(32)20-27(19-23)34-31(39)37-16-14-35(2)15-17-37/h3-9,18-20,22,25H,10-17,21H2,1-2H3,(H,33,38)(H,34,39)/t22-/m1/s1
InChI Key ZGUISYSWQQIAHK-JOCHJYFZSA-N
Bioactivity Comments
In vitro, compound 19 inhibits PL-pro enzymatic activity, reduces its immunosuppressive function and abbrogates viral replication in human cells (IC50 180 nM) [1].
Selectivity at other protein targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
CoV Papain-like protease SARS-CoV-2 Inhibitor Binding 5.6 pKd - 1
pKd 5.6 (Kd 2.6x10-6 M) [1]
Description: Binding affinity by surface plasma resonance (SPR)
CoV Papain-like protease SARS-CoV-2 Inhibitor Inhibition 6.4 pIC50 - 1
pIC50 6.4 (IC50 4.4x10-7 M) [1]
Description: Inhibition of PL-pro-mediated substrate cleavage in vitro